Insider · CIK 0001874199

Washburn Theodore James Jr.

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001874199

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-03	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−5,272 sh	$28.88	−$152K	868
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+2,350 sh	—	—	3,293
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−698 sh	$28.96	−$20.2K	2,595
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+2,450 sh	—	—	4,970
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−727 sh	$28.96	−$21.1K	4,243
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+2,695 sh	—	—	6,938
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−798 sh	$28.96	−$23.1K	6,140
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−2,350 sh	—	—	0
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−2,450 sh	—	—	2,450
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−2,695 sh	—	—	5,390
2026-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Principal Accounting Officer	AAward	+8,452 sh	—	—	8,452
2025-09-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−8,546 sh	$36.87	−$315K	868
2025-03-03	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−231 sh	$35.54	−$8,209.74	6,038
2025-03-03	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−697 sh	$35.54	−$24.8K	7,691
2025-03-03	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−727 sh	$35.54	−$25.8K	9,414
2025-03-03	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−2,450 sh	—	—	4,900
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+777 sh	—	—	6,269
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+2,350 sh	—	—	8,388
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+2,450 sh	—	—	10,141
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Principal Accounting Officer	AAward	+8,085 sh	—	—	8,085
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Principal Accounting Officer	AAward	+6,142 sh	—	—	6,142
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−777 sh	—	—	0
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−2,350 sh	—	—	2,350
2025-02-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−2,272 sh	$34.39	−$78.1K	5,437
2025-02-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+6,896 sh	—	—	7,709
2025-02-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−6,896 sh	—	—	0
2024-11-08	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−772 sh	$56.09	−$43.3K	813
2024-06-03	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−1,362 sh	$44.39	−$60.5K	1,524
2024-03-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−1,913 sh	$31.75	−$60.7K	2,886
2024-03-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−295 sh	$32.57	−$9,608.15	3,368
2024-03-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−919 sh	$32.57	−$29.9K	4,799
2024-03-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+777 sh	—	—	3,663
2024-03-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+2,350 sh	—	—	5,718
2024-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Principal Accounting Officer	AAward	+7,350 sh	—	—	7,350
2024-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−777 sh	—	—	777
2024-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−2,350 sh	—	—	4,700
2024-02-20	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−504 sh	$26.63	−$13.4K	2,741
2024-02-14	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−273 sh	$25.14	−$6,863.22	3,245
2024-02-12	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+777 sh	—	—	3,518
2024-02-12	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−777 sh	—	—	0
2023-08-07	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−2,918 sh	$25.39	−$74.1K	2,741
2023-08-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+4,150 sh	—	—	6,891
2023-08-01	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−1,232 sh	$26.26	−$32.4K	5,659
2023-08-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−4,150 sh	—	—	0
2023-03-03	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−504 sh	$24.29	−$12.2K	2,741
2023-03-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+777 sh	—	—	3,518
2023-03-01	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Principal Accounting Officer	FTax Payment	−273 sh	$25.31	−$6,909.63	3,245
2023-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Principal Accounting Officer	AAward	+7,050 sh	—	—	7,050
2023-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−777 sh	—	—	1,554
2023-02-16	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−233 sh	$27.21	−$6,339.93	2,668

Recent filings

Accepted (ET)
Mar 54
Washburn Theodore James Jr.0001439222-26-000046
SEC(opens sec.gov)
Mar 34
Washburn Theodore James Jr.0001439222-26-000034
SEC(opens sec.gov)
Sep 94
Washburn Theodore James Jr.0001439222-25-000102
SEC(opens sec.gov)
Mar 44
Washburn Theodore James Jr.0001439222-25-000011
SEC(opens sec.gov)

Companies

AGIOS PHARMACEUTICALS, INC.Principal Accounting OfficerAGIO

Address

88 SIDNEY STREET

CAMBRIDGE, MA, 02139